ALLUCENT (UK) LIMITED
Get an alert when ALLUCENT (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.2m
+36.8% highest in 3 filed years
Net assets
£2.5m
+40.7% vs 2024
Employees
73
-9.9% vs 2024
Profit before tax
£722k
+140.3% highest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £15,877,737 | £15,324,563 | £24,792,551 | +61.8% | |
| Operating profit | -£2,218,075 | -£1,793,860 | £722,562 | +140.3% | |
| Profit before tax | -£2,221,585 | -£1,793,862 | £722,414 | +140.3% | |
| Net profit | -£2,224,796 | -£1,796,957 | £718,549 | +140% | |
| Cash | £597,934 | £841,448 | £1,151,375 | +36.8% | |
| Total assets less current liabilities | £3,560,530 | £1,763,573 | £2,482,122 | +40.7% | |
| Net assets | £3,560,530 | £1,763,573 | £2,482,122 | +40.7% | |
| Equity | £3,560,530 | £1,763,573 | £2,482,122 | +40.7% | |
| Average employees | 56 | 81 | 73 | -9.9% | |
| Wages | £5,486,339 | £6,220,341 | £6,170,778 | -0.8% | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -14.0% | -11.7% | 2.9% | |
| Net margin | -14.0% | -11.7% | 2.9% | |
| Return on capital employed | -62.3% | -101.7% | 29.1% | |
| Gearing (liabilities / total assets) | 81.8% | 91.7% | 91.5% | |
| Current ratio | 1.19x | 1.06x | 1.07x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ALLUCENT (UK) LIMITED 2023-02-20 → present
- PHARM-OLAM INTERNATIONAL (UK) LIMITED 1995-11-14 → 2023-02-20
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- UHY Hacker Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- ALLUCENT (UK) LIMITED · parent
- Allucent (Belgium) BVBA 99%
- Allucent (IT) S.R.L. 100%
- Allucent (FR) SAS 100%
- Allucent (ES) SL 100%
- Allucent (PL) (Polska) Sp z.o.o. 100%
- Allucent DOO Beograd 100%
- Allucent (CZ) s.r.o. 100%
- Allucent (India) Pvt. Ltd 100%
- Allucent Klinik Arastirma Ve Deney Ticaret Limited Sirketi 100%
- Allucent (HU) Kft 100%
- Allucent (HR) d.o.o. 100%
- Allucent Research Israel Ltd 100%
- Pharm-Olam (Bulgaria) EOOD 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BRAND, Howard | Secretary | 2025-11-12 | — | — |
| BRAND, Howard | Director | 2025-01-08 | Apr 1972 | American |
| STAFFORD, Paula Brown | Director | 2025-01-08 | May 1964 | American |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRENNAN, Chris | Secretary | 2021-12-16 | 2025-11-12 |
| MUNK, Susan | Secretary | 1995-11-14 | 2017-11-20 |
| AGROSKIN, Daniel | Director | 2021-12-16 | 2025-01-08 |
| BARRY, John David | Director | 2017-11-20 | 2020-03-27 |
| BRENNAN, Christopher | Director | 2025-01-08 | 2025-11-12 |
| DAVIE, Robert James | Director | 2020-03-27 | 2021-12-16 |
| GASSEN, Natalie Kay | Director | 2017-11-20 | 2022-08-01 |
| GOLDBERG, Mark Alan | Director | 2021-12-16 | 2025-01-08 |
| GRANGE, David Lawrence | Director | 2017-11-20 | 2020-03-27 |
| KHAN, Yamin | Director | 2017-11-20 | 2019-07-26 |
| MUNK, Susan | Director | 1997-02-12 | 2017-11-20 |
| MUNK, Zev Moshe | Director | 1995-11-14 | 2017-11-20 |
| NATORFF, Benona Lillian, Dr | Director | 1997-02-12 | 2000-10-23 |
| SHIMOTA, Richard William | Director | 2021-12-16 | 2025-01-08 |
| STROTHMAN, Peter Maurice | Director | 2021-12-16 | 2025-01-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Zev Moshe Munk | Individual | Significant influence | 2016-04-06 | Ceased 2020-06-19 |
| Allucent (Uk) Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 116 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-12-09 | AA | accounts | Accounts with accounts type full | |
| 2025-11-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-13 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-11-13 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-06 | AA | accounts | Accounts with accounts type medium | |
| 2024-01-06 | AA | accounts | Accounts with accounts type medium | |
| 2023-12-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-05 | PSC05 | persons-with-significant-control | Change to a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.